Acura Pharma (ACUR) Tops Q3 EPS by 8c

Acura Pharma (NASDAQ: ACUR) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $218 thousand versus the consensus estimate of $230 thousand.

For earnings history and earnings-related data on Acura Pharma (ACUR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c